Physiological Effect: Decreased Mitosis
✉ Email this page to a colleague
Drugs with Physiological Effect: Decreased Mitosis
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | CONDYLOX | podofilox | GEL;TOPICAL | 020529-001 | Mar 13, 1997 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Chartwell Rx | FULVICIN P/G | griseofulvin, ultramicrosize | TABLET;ORAL | 061996-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Chartwell Rx | FULVICIN P/G | griseofulvin, ultramicrosize | TABLET;ORAL | 061996-002 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Chartwell Rx | FULVICIN P/G 165 | griseofulvin, ultramicrosize | TABLET;ORAL | 061996-003 | Apr 6, 1982 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |